Point-of-care media is advertising delivered inside a clinical environment, primarily waiting rooms and exam rooms in physician offices, but also pharmacies, hospitals and the digital workflow tools clinicians use during a visit. The category sits apart from general out-of-home or display advertising because its audience is defined by a physical or workflow location tied to a health interaction, and because buyers are overwhelmingly pharmaceutical brands. It exists because marketers have long sought a moment when a patient or prescriber is actively thinking about a condition, one broadcast and social advertising cannot replicate with the same precision. Behind the screens sits a supply chain: network operators who install devices in healthcare locations, demand-side platforms that let brands buy inventory alongside other channels, and a measurement infrastructure built to satisfy compliance requirements consumer advertising does not carry.

How the supply chain works

A network operator negotiates placement agreements with physician practices, hospital systems or pharmacy chains, typically offering screens at no cost in exchange for the right to sell advertising space. PatientPoint, founded in 1987 and based in Cincinnati, describes itself as the nation's largest point-of-care publisher, with its Digital Campaign Report covering digital screens across more than 30,000 doctors' offices. CheckedUp operates comparably under its Explorer Waiting Room TV product, displays installed primarily in patient waiting rooms.

A pharmaceutical brand buys a campaign directly through the operator's sales team or, increasingly, through a demand-side platform built for healthcare, such as DeepIntent or StackAdapt. DeepIntent, founded in 2016, unites media, identity and clinical data for privacy-safe, omnichannel marketing; in March 2026 it launched Helix, a HIPAA-compliant marketing cloud covering more than 3.7 million providers and over 240 million patient lives, opened to third-party partners. HIPAA, the 1996 U.S. law governing patient health information, applies unevenly here: patient-facing campaigns using identifiable data trigger its authorization requirements, while provider-only campaigns generally fall outside its scope. Provider-facing targeting typically runs on the National Provider Identifier, or NPI, the standardized number the government assigns to licensed clinicians. StackAdapt launched self-serve NPI targeting on Jan. 6, 2026, and DeepIntent's three EHR deals in May 2026 introduced NPI-level trigger-based messaging spanning six electronic health record systems and 158,000 doctors.

Point-of-care inventory now extends into digital out-of-home too. DeepIntent's August 2026 partnership with Vistar Media, owned by T-Mobile Advertising Solutions since a $600 million acquisition completed in February 2025, routed point-of-care screens in pharmacies and transit hubs into the same buying interface used for streaming and clinical inventory. Pharmacy front-of-store screens, however, are not the same inventory as waiting-room or exam-room displays, and the regulatory perimeter differs.

Origin and evolution

Place-based healthcare advertising predates digital screens by decades; waiting-room magazines circulated well before the internet. The category's screen-based form took shape in the 1990s: PRN traces its founding to 1992, and AccentHealth, one of the earliest dedicated point-of-care television networks, co-founded the Point-of-Care Communication Council trade group in May 2013.

The category's most consequential early chapter was a fraud scandal rather than a product launch. Rishi Shah founded ContextMedia in 2006, installing condition-specific screens in waiting rooms and selling advertising to pharmaceutical manufacturers. The business, rebranded Outcome Health, raised roughly 500 million dollars in May 2017 at a valuation exceeding 5 billion dollars, from investors including Goldman Sachs and Alphabet's CapitalG. An October 2017 Wall Street Journal investigation revealed the company had, from 2011 to 2017, sold clients advertising on more screens than it had installed, then billed as if campaigns were delivered in full, resulting in at least 45 million dollars in overbilled services to clients including Pfizer and Novo Nordisk, according to the Department of Justice. Founders Shah and Shradha Agarwal were convicted of fraud in 2023; an appeals court upheld those convictions in August 2026. Outcome Health merged with rival PatientPoint in 2021.

That episode reshaped how the industry approached measurement. The Media Rating Council, established in 1963, granted PatientPoint accreditation for its Digital Campaign Report on Jan. 30, 2024, the first point-of-care service to earn MRC accreditation, directly addressing the kind of unverified delivery claims that enabled the fraud. PatientPoint expanded that accreditation on April 9, 2026, covering its complete national network, and CheckedUp became the second operator to earn MRC accreditation on June 10, 2026, for its TV Video Ad Plays and Explorer Waiting Room TV Engagement metrics. Spend passed 1 billion dollars in 2024 and reached approximately 1.2 billion dollars in 2025.

Why the channel matters to marketers

Point-of-care media occupies a position pharmaceutical marketers describe as structurally different: the audience is not merely interested in a health topic but physically present as care is being discussed. In a survey commissioned by PatientPoint, 94 percent of pharma marketers reported advertising at the point of care, and 75 percent cited compliance and message control as a key advantage. Separate research from Phreesia, covering more than 9,000 patients, found 92 percent said point-of-care content helped them ask the right questions, and 23 percent who viewed medication content there went on to ask their doctor about it, against 11 percent who did so after a television ad outside a clinical setting.

That compliance advantage gained weight after a September 2025 enforcement push, when the FDA and HHS announced a broad initiative targeting direct-to-consumer pharmaceutical advertising, issuing roughly 100 cease-and-desist letters and warning that patients were not seeing a fair balance of risk and benefit information. Point-of-care displays offer more physical space for Important Safety Information than a broadcast spot, and because creative is typically reviewed by practice administrators before placement, brands gain a compliance checkpoint largely absent from open social and programmatic display. Metrics distinctive to the channel have become a selling point too: DeepIntent's platform tracks Audience Quality, verified provider reach and script lift, a patented method measuring whether a campaign correlated with changed prescribing behavior, an outcome consumer categories do not track.

Limitations, disputes and open questions

The Outcome Health fraud remains the channel's defining cautionary example. It demonstrated that a place-based medium is not inherently more trustworthy than digital display simply because its screens sit in a clinical setting; verifying device count and actual delivery matters as much in a waiting room as in a programmatic auction. MRC accreditation addresses that gap only for operators who have obtained it, and as of mid-2026, PatientPoint and CheckedUp are the only two holding it, meaning most inventory trades without independent, audited delivery verification.

Measurement extending beyond delivery counts into attribution carries a separate limitation. Linking a change in prescribing behavior to a specific ad exposure requires connecting media delivery to clinical data, a chain more direct for in-workflow inventory than for broadcast formats. When DeepIntent extended its point-of-care partnership into digital out-of-home through Vistar Media in August 2026, the announcement did not describe how DOOH impressions would be tied to script-lift outcomes, since a broadcast screen delivers to whoever happens to be present, not an identifiable audience. The category also suffers from definitional slippage: Perion's August 2026 acquisition of in-store operator PRN, including more than 2,200 pharmacy locations, described the inventory as point-of-care media without distinguishing pharmacy front-of-store screens from clinical waiting-room and exam-room displays, which carry a different regulatory perimeter and are bought by different teams.

Direct-to-consumer pharmaceutical advertising broadly, of which patient-facing point-of-care is one channel, faces criticism dating to when the FDA first permitted broadcast drug advertising: that ads may encourage patients to request more expensive treatments than necessary, and that companies have at times spent more promoting drugs with lower rated clinical benefit than higher-benefit alternatives, per a 2023 academic analysis. Proponents argue the channel's physician-adjacent setting mitigates that risk relative to broadcast or social formats; critics note the claim remains untested against the channel's own outcome data.

Disambiguation

Point-of-care media should be distinguished from adjacent terms that overlap in vocabulary but describe different inventory or regulatory treatment.

Digital out-of-home (DOOH) is the broader category of programmatically buyable outdoor and place-based digital screens, spanning billboards, transit displays and retail signage. Point-of-care media is a specialized subset trading on healthcare-specific verification; only a portion of DOOH supply qualifies.

Retail media and in-store media describe advertising sold against a retailer's own footprint, typically funded by trade or shopper-marketing budgets. Pharmacy front-of-store screens sit at that boundary, commercially closer to general in-store advertising than to exam-room and waiting-room inventory.

Endemic media, in healthcare, refers to publishers whose audience is defined by clinical practice, such as trade publications for physicians. It can include point-of-care inventory but also covers non-place-based channels like clinician websites.

Healthcare professional (HCP) targeting describes reaching licensed clinicians with advertising, most often through NPI-based identity matching, across any channel. Point-of-care media frequently uses HCP targeting as its identity layer, but that targeting also runs across channels unrelated to a physical point of care.

Recent developments

The channel's supply side consolidated further through 2026. DeepIntent disclosed three point-of-care EHR deals within a single week in late May, then extended into digital out-of-home through the Vistar Media partnership on Aug. 18. Perion Network's acquisition of PRN for up to 12 million dollars, announced Aug. 25, added more than 2,200 pharmacy locations to Perion's retail media stack a week later.

Measurement infrastructure expanded too. The Video Advertising Bureau added PurpleLab, a healthcare analytics company combining more than 14 billion annual medical claims and more than 330 million U.S. patient lives, to its measurement vendor directory on July 21, 2026, alongside IQVIA Digital, credited with measurement spanning more than 318 million non-identified patients. PatientPoint launched PatientPoint Health Audiences in March 2026, matching condition-relevant audiences to waiting-room locations using claims data, part of a shift toward programmatic activation of inventory historically sold only through direct, managed-service relationships.

Timeline

  • 1987: PatientPoint is founded in Cincinnati, Ohio
  • 1992: PRN, an in-store network operator later serving healthcare venues, is founded
  • 2006: Rishi Shah founds ContextMedia, later renamed Outcome Health, installing screens in physician waiting rooms
  • May 2013: AccentHealth co-founds the Point-of-Care Communication Council
  • May 2017: Outcome Health raises approximately 500 million dollars at a valuation exceeding 5 billion dollars
  • October 2017: A Wall Street Journal investigation reveals Outcome Health's advertising-delivery fraud scheme
  • 2021: Outcome Health merges with PatientPoint
  • 2023: Outcome Health founders Rishi Shah and Shradha Agarwal are convicted of fraud
  • Jan. 30, 2024: The Media Rating Council grants PatientPoint the first-ever point-of-care accreditation
  • 2024: Point-of-care media spend passes 1 billion dollars
  • Jan. 6, 2026: StackAdapt launches self-serve NPI targeting for pharmaceutical advertisers
  • March 19, 2026: DeepIntent launches Helix, opening HIPAA-compliant healthcare data infrastructure to third parties
  • March 24, 2026: PatientPoint launches PatientPoint Health Audiences, its programmatic-buying capability
  • April 9, 2026: PatientPoint's MRC accreditation expands to its complete national network of digital screens
  • May 26 to 28, 2026: DeepIntent completes three point-of-care EHR deals with OptimizeRx, epocrates and Lane4.io
  • June 10, 2026: The Media Rating Council accredits CheckedUp, the second point-of-care publisher to earn the distinction
  • July 21, 2026: The Video Advertising Bureau adds PurpleLab and IQVIA Digital to its measurement vendor directory
  • Aug. 18, 2026: DeepIntent routes Vistar Media's point-of-care and digital out-of-home inventory into its DSP
  • Aug. 25, 2026: Perion Network acquires in-store operator PRN, including more than 2,200 pharmacy locations
  • Aug. 26, 2026: A U.S. appeals court upholds the fraud convictions of Outcome Health's founders

Summary

Who: Point-of-care media is operated by network publishers including PatientPoint, CheckedUp, PRN and AccentHealth's successor entities, bought by pharmaceutical and healthcare brands through demand-side platforms such as DeepIntent and StackAdapt, and measured under standards set by the Media Rating Council.

What: Point-of-care media is advertising placed inside clinical environments, primarily physician waiting rooms and exam rooms, but extending to pharmacies, hospitals and clinician digital workflow tools such as electronic health records, targeting patients and healthcare providers at the moment of a health interaction.

When: The category's modern, screen-based form emerged in the 1990s and early 2000s; independent measurement arrived only in January 2024 with PatientPoint's first Media Rating Council accreditation, and the channel has continued expanding into digital out-of-home and programmatic buying through 2026.

Where: Physician offices, hospitals, pharmacies and, increasingly, digital clinical workflow tools across the United States, where the overwhelming majority of documented point-of-care advertising activity and spend is concentrated.

Why: Point-of-care media matters to pharmaceutical marketers because it reaches patients and prescribers at a moment of active clinical engagement that other channels cannot replicate, and because its physical, reviewable format offers a structural advantage for meeting fair-balance and safety-disclosure regulatory requirements, though the channel's history includes one of advertising's largest verified-delivery fraud cases and independent audit still covers only a fraction of its total inventory.